Salta al contenuto principale

TNF receptor superfamily member 11b

The TNFRSF11B gene provides instructions for making a protein that plays an important role in bone remodeling, a normal process in which old bone is broken down and replaced by new bone. The TNFRSF11B protein is involved in the regulation of specialized cells called osteoclasts, which break down bone tissue during bone remodeling.

Scelte video per Genes
Video library

Normal function

The TNFRSF11B gene provides instructions for making a protein that plays an important role in bone remodeling, a normal process in which old bone is broken down and replaced by new bone. The TNFRSF11B protein is involved in the regulation of specialized cells called osteoclasts, which break down bone tissue during bone remodeling.

The TNFRSF11B protein belongs to a larger family of receptor proteins. Other proteins, called ligands, can fit into specific sites on receptor proteins like a key into a lock. Together, ligands and their receptors trigger signaling pathways that affect cell development and function. The TNFRSF11B protein works outside of the cell membrane.

The TNFRSF11B protein and a receptor protein called RANK can each attach to a ligand called RANKL. Because RANKL can only bind to one of these proteins at a time, the TNFRSF11B protein and RANK compete with one another. When RANKL is bound to RANK, a series of chemical signals cause osteoclasts to mature and turn on. This leads to the breakdown of bone. When RANKL is bound to the TNFRSF11B protein, these chemical signals are blocked. The TNFRSF11B protein is called a "decoy" receptor protein because no chemical signals are transmitted when RANKL is attached to this protein.

By influencing the amount of RANKL that is available to bind to RANK and activate osteoclasts, the TNFRSF11B protein plays a critical role in regulating the process of bone remodeling.

Conditions referring to this gene or chromosome

Altri nomi

OCIF

OPG

osteoclastogenesis inhibitory factor

TR1

tumour necrosis factor receptor superfamily, member 11b

Related patient information and medicines

Immunosoppressione

Patient information leaflet

Immunosoppressione

Mycophenolate... Monoclonal antibodies - of which there are many ending in "mab", such as bevacizumab, rituximab and trastuzumab. Anti-TNF drugs such as etanercept Etanercept , infliximab, adalimumab, certolizumab and golimumab. (TNF stands for anti tumour necrosis factor, and some of the "mab" medicines above act against TNF, so there is some.

Medicinali biologici per l'artrite reumatoide

Patient information leaflet

Medicinali biologici per l'artrite reumatoide

They are made by living o... For example, some of these biological medicines block a chemical called tumour necrosis factor alpha (TNF-alpha) which plays an important role in causing inflammation in the joints. Medicines that block TNF includono adalimumab, certolizumab pegol, etanercept, golimumab, and infliximab. The other biological medicines.

Idrosadenite suppurativa

Patient information leaflet

Idrosadenite suppurativa

Idrosadenite suppurativa is a long-term (chronic) pelle condition that leads to painful and repeated lumps of pus (boils or abscesses). Hidradenitis suppurativa tends to run in families; about one-third of people with hidradenitis suppurative have a family member who is affected. The most promising of these treatments are monoclonal antibodies,.

Spondiloartrite assiale

Patient information leaflet

Spondiloartrite assiale

Biological medicines Biologics can be used to control the disease process. The main ones used for axial spondyloarthritis are called tumour necrosis factor (TNF) inhibitors (adalimumab, certolizumab pegol, etanercept, golimumab or infliximab). Other medicines, such as secukinumab, bimekizumab or ixekizumab, may be used if TNF inhibitors have been.

Spondilite anchilosante

Patient information leaflet

Spondilite anchilosante

In ankylosing spondylitis, a chemical called cytokine tumour necrosis factor alpha (TNF-alpha) is involved in causing inflammation. Certain medicines in a group called TNF-alpha inhibitors... TNF-alpha inhibitors are also sometimes called anti-TNF-alpha drugs. In the UK the National Institute for Health and Care Excellence (NICE) recommends that.

Sindrome di Marfan

Patient information leaflet

Sindrome di Marfan

The following lists the most common problems and symptoms that may develop. Treatments are available for most of these problems. It can also cause head... What causes Marfan syndrome. Marfan syndrome is caused by a change (mutation) in dello genetiche material on one of your chromosomes (chromosome number 15). The gene that is affected is responsible.

Ulteriori letture e riferimenti

Storia dell'articolo

Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.
  • 20 Nov 2025 | Ultima versione
  • 1 Nov 2025 | Pubblicato originariamente

Partecipa alla conversazione

Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.

Avvertenza: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Farmacia online, trattamenti e servizi sanitari

Accesso semplice a trattamenti affidabili e servizi sanitari online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Iscriviti alla newsletter di Patient

La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.

Per favore, inserisci un indirizzo email valido

Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.